Notably, the significant differences in EGFR gene mutations in patients with lung cancer in different regions is supported by some reports, but few studies on the genetic testing for patients with lung adenocarcinoma in Zunyi [12]. The gene discussed is EGFR; the disease is lung carcinoma.